Global reemergence of tuberculosis: are host defense peptides an option to ameliorate disease burden?

Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease
Mario Alberto Flores-Valdez, Sidharth Chopra

Abstract

Tuberculosis is the most relevant infectious disease worldwide according to the estimates of the World Health Organization, and despite being a curable disease, it requires a 6-9-month therapy with multiple antibiotics. Intermittent drug therapy due to noncompliance or poor delivery of therapy promotes the emergence of bacterial strains showing resistance to multiple drugs and the rise of extremely drug-resistant strains. Moreover, increased antibiotic resistance has been observed for several microorganisms, including extremely drug-resistant tuberculosis, vancomycin-resistant Enterococcus faecalis, or methicillin-resistant Staphylococcus aureus. In vitro, cathelicidin induction results in enhanced mycobacterial clearance, and synthetic human neutrophil peptides had a rather modest bactericidal effect in Mycobacterium tuberculosis-infected mice. In vivo therapeutic efficacy of improved molecules that show enhanced bactericidal action in vitro remains to be tested.

References

Dec 1, 1989·The Journal of Clinical Investigation·M C TerritoR Lehrer
Jan 5, 1996·Biochemical and Biophysical Research Communications·C B ParkS C Kim
May 1, 1999·Antimicrobial Agents and Chemotherapy·M Wu, R E Hancock
Nov 23, 2000·Biochemistry·L OtvosM Blaszczyk-Thurin
Feb 13, 2001·Antimicrobial Agents and Chemotherapy·S SharmaG K Khuller
Apr 12, 2002·Current Pharmaceutical Design·Margherita ZanettiRaffaella Circo
Apr 26, 2002·Trends in Microbiology·Mark J Pallen
Oct 9, 2002·Molecular Microbiology·Artur SchmidtchenLars Björck
Jul 3, 2003·The Lancet Infectious Diseases·Amy Sarah GinsburgWilliam R Bishai
Sep 2, 2003·Nature Reviews. Immunology·Tomas Ganz
Nov 19, 2003·Scandinavian Journal of Infectious Diseases·Victor Nizet, Richard L Gallo
Sep 21, 2004·The Journal of Infectious Diseases·Anjana KalitaG K Khuller
Nov 25, 2004·Antimicrobial Agents and Chemotherapy·Magdalena Sieprawska-LupaJan Potempa
Feb 11, 2005·Nature Reviews. Microbiology·Kim A Brogden
Jul 26, 2005·Nature Biotechnology·Kai HilpertRobert E W Hancock
Dec 13, 2005·American Journal of Respiratory Cell and Molecular Biology·Y Elaine LauDonald J Davidson
Mar 1, 2006·Respiratory Research·Mark P RoganNoel G McElvaney
Mar 30, 2006·Antimicrobial Agents and Chemotherapy·Jon-Paul S PowersRobert E W Hancock
Aug 17, 2006·Current Topics in Microbiology and Immunology·D M E BowdishR E W Hancock
Sep 26, 2006·Nucleic Acids Research·Christophe MarchandYves Pommier
Feb 21, 2007·Cellular and Molecular Life Sciences : CMLS·N Mookherjee, R E W Hancock
Mar 27, 2007·Nature Biotechnology·Monisha G ScottRobert E W Hancock
May 22, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Adrian R MartineauRobert J Wilkinson
May 23, 2007·Proceedings of the National Academy of Sciences of the United States of America·Min LiMichael Otto
Jul 4, 2007·The Journal of Clinical Investigation·Adrian R MartineauRobert J Wilkinson

❮ Previous
Next ❯

Citations

Dec 13, 2012·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Yessica Yadira Llamas-GonzálezMario Alberto Flores-Valdez
Jun 30, 2019·International Journal of Environmental Research and Public Health·Tafese BoshaHans K Biesalski

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.